While I currently work with all sorts of macro-fundamental indicators and inter-market ratio charts, I started out just loving the act of creating and analyzing nominal stock and market charts.…
First off, I believe we are entering a rising interest rate environment, quite possibly in line with the preferred view of inflationary pressures out ahead. In that regard, I want…
Here is the daily BKX stringing several up days together, but starting to get over bought. I have held the Regional Bank fund KRE (per NFTRH+ notes in the weekly…
This update on the Biotech iShares works as both an NFTRH+ update and a regular update.
For the purposes of our regular updating, a breakout here would indicate that speculative bullish money is spreading out to Biotech, which helps the rally’s internals and speculative inputs.
This '+' update is being sent to the entire list because it has macro market elements in it pertaining to the Biotech sector and its leadership vs. Nasdaq 100. The…
Okay, so you tell me. Is speculative leadership alive and well in this market? Beuller? We noted in the last NFTRH edition that market sentiment had become positive on a…
Biotech, an important momentum leader to the stock market, is going to need to think about finding support soon lest this become something more than routine. IBB has already made…
Yesterday we noted the Biotechs had lower to go, and lower they went. Typical of today's momo driven markets IBB took the express elevator right to the projected support zone…
I would be careful here on Biotech. The reversal candle signaled a fallout from a mini blow off. The level to which IBB became over bought implied the momo players…
Aside from numerous 'straight' markets and out there indicators we follow in NFTRH, we also follow discrete individual sectors like the Semiconductors and the Biotechs, just because they are of…